China Macro 2026-11-19 中文 PDF

NIGHTLY INTELLIGENCE BRIEF · Day Digest

Central Treasury Places CNY100bn in 28-Day Bank Deposits at 1.30% as Banks Defer or Cancel CNY80bn of Bond Deals - Targeted Liquidity Meets a 10.1% Private-Investment Drop

China's macro picture split between targeted liquidity and tougher private-sector funding: the central treasury placed CNY100bn into one-month bank deposits at a 1.30% winning rate, yet seven banks deferred or canceled bond issuance totaling CNY80bn on a basic basis, or up to CNY90bn including over-allotments, as AAA- three-year bank Tier-2 and perpetual-bond yields rose to 1.73% and 1.75%. Private fixed-asset investment fell 10.1% in January-August, against a 7.2% decline in total fixed-asset investment, while three Beijing residential sites fetched CNY9.247bn. Alibaba's revenue rose 10% to CNY271.52bn and beat the CNY270.53bn estimate, but adjusted net profit was CNY19.91bn versus CNY26.61bn expected and adjusted earnings per ADS were CNY8.10 versus CNY10.75 expected. Yet October power and storage battery sales jumped 38.8% year on year to 230.4GWh. The China-US summit ended in Shenzhen, where President Donald Trump said the United States does not support Taiwan independence and called for cooperation in agriculture, energy and super-intelligence. The near-term domestic test is whether bank funding conditions ease without a further slide in private investment.

0. Daily Arc

  • **[NEW] Daily arc:** Targeted liquidity and weak capital formation pulled in opposite directions: the central treasury awarded CNY100bn in 28-day commercial-bank deposits at a 1.30% rate, while seven banks had deferred or canceled bond issuance totaling CNY80bn on a basic basis, or up to CNY90bn with over-allotments [1][2].
  • **[NEW] Domestic tension:** January-August private fixed-asset investment fell 10.1%, total fixed-asset investment fell 7.2%, and Beijing still cleared three residential sites for CNY9.247bn, including premiums of 9% and 7.2% on two parcels [3][4].
  • **[NEW] Source-quality flag:** The APEC bundle contains several headline-only reports and a broad comment from a US healthcare executive, while the Xinhua feature on the capital's 15th Five-Year Plan opening-year pulse is narrative color; the quantified corporate, official-data and auction items provide the packet's more granular evidence [5][6][7][8][9][10][11][1][4][12][3].
  • **[ONGOING] Net read:** The unresolved issue is whether the narrow cash-management operation transmits into bank funding and private investment [1][2][3].

1. Liquidity and Bank Funding

  • **[NEW] Cash-management operation:** The central treasury's cash-management office ran a single-price auction from 9:00 a.m. to 9:30 a.m. on November 19 for a one-month, 28-day deposit, awarded the full CNY100bn and deposited the funds with winning banks that day while pledging sufficient bonds [1].
  • **[ESCALATED] Issuance retreat:** Hubei Bank postponed a CNY2bn green financial bond; Industrial and Commercial Bank of China and Shanghai Pudong Development Bank each postponed CNY20bn perpetual bonds; Zhangjiagang Rural Commercial Bank, Bank of Zhengzhou and Industrial Bank delayed ordinary financial bonds; and Dongguan Rural Commercial Bank canceled a financial bond of up to CNY2bn [2].
  • **[ONGOING] Yield backdrop:** On November 17, implied AAA- three-year commercial-bank Tier-2 and perpetual-bond yields stood at 1.73% and 1.75%, up about 15 and 14 basis points from October 20, respectively [2].
  • **[ONGOING] Allocation demand:** Fudan Development Research Institute assistant researcher Shi Shuo said redemptions from wealth-management products and pressure from credit-bond selling had weakened institutional allocation demand [2].
  • **[ONGOING] Falsifiable test:** A resumption of postponed issuance with yields falling from 1.73% and 1.75% would ease the funding squeeze; continued delays with higher yields would confirm persistence [2].

2. Investment, Land and Corporate Results

  • **[ONGOING] Private capital:** Lian Ping's analysis reported national fixed-asset investment excluding rural households down 7.2% year on year in January-August, private fixed-asset investment down 10.1% and tertiary-industry investment down 9.9%; it noted that, in China, private investment has long represented more than half of total fixed-asset investment [3]. Lian Ping argued for policies that ease financing difficulty and cost while addressing profitability, expectations, the institutional environment and innovation incentives [3].
  • **[NEW] Beijing land:** Three residential parcels generated CNY9.247bn against aggregate starting prices of CNY8.568bn: the Zhongjian Zhidi-Swire Properties consortium won the west plot for CNY4.905bn at a 9% premium, the Maoyuan-BBMG consortium won the east plot for CNY4.0736bn at a 7.2% premium, and Beijing Infrastructure Investment Development won the Pinggu parcel at its CNY268m starting price [4].
  • **[NEW] Alibaba:** Fiscal 2027 second-quarter revenue rose 10% to CNY271.52bn, beating the CNY270.53bn estimate, but adjusted net profit of CNY19.91bn missed the CNY26.61bn estimate and adjusted earnings per ADS of CNY8.10 missed the CNY10.75 estimate; operating profit was CNY29.116bn, up 443%, and net profit attributable to common shareholders was CNY64.535bn, up 207% [10].
  • **[NEW] Hygon Information Technology:** The company made its first on-exchange buyback of 1.3767 million shares, equal to 0.06% of 2.324 billion shares, paying CNY235 million at a high of CNY174.99 and low of CNY162.69 per share, excluding commissions and other trading fees [11].
  • **[NEW] Shengjian Technology:** After three consecutive limit-up sessions, the company said its electronic-chemicals business does not include photoresist; its main product, stripping solution, is a cleaning reagent used alongside photoresist, and the segment generated CNY49.4944 million, or 4.41% of 2025 main-business revenue [13].
  • **[ONGOING] Corporate test:** The next falsifiable checkpoint is whether Alibaba's adjusted profit and adjusted earnings per ADS converge toward estimates while Hygon's first repurchase develops into a sustained capital-return signal [10][11].

3. Trade, Energy and Industry

  • **[NEW] Battery demand:** China's October power and storage battery sales reached 230.4GWh, up 3.4% month on month and 38.8% year on year; power-battery sales were 159.3GWh, up 6.7% month on month and 28.1% year on year, while storage-battery sales were 71.1GWh, down 3.3% month on month but up 70.5% year on year [12].
  • **[ONGOING] Cumulative growth:** January-October power and storage battery sales totaled 1,912.1GWh, up 55.1% year on year; power batteries totaled 1,245.6GWh, up 36.8%, and storage batteries totaled 666.4GWh, up 106.5% [12].
  • **[NEW] Korea trade talks:** China and South Korea substantively completed negotiations to upgrade their free-trade agreement, with China committing to most-favored-nation treatment for South Korean films and games [14].
  • **[NEW] Vehicle exports:** A train carrying 203 China-made new-energy vehicles departed Zhengzhou International Land Port, bringing the cumulative number of export block trains to 10,000 [15].
  • **[NEW] Hydrogen transport:** A 195km pure-hydrogen pipeline from Darhan Muminggan United Banner to central Baotou entered operation, described as China's first pure-hydrogen long-distance pipeline exceeding 100km; it was selected for the National Energy Administration's first batch of energy-sector hydrogen pilot projects [16].
  • **[NEW] Dubai trade:** The Dubai Chamber of Commerce said China had become the largest source of Dubai's vehicle imports [17].

4. Healthcare, Labor and Data Assets

  • **[NEW] Ibrutinib approval:** Tianyu's wholly owned Zhejiang Nuode Pharmaceutical received a drug-registration certificate from the National Medical Products Administration for ibrutinib capsules, which the company said applies to mantle-cell lymphoma, chronic lymphocytic leukemia or small lymphocytic lymphoma, and Waldenstrom macroglobulinemia [18].
  • **[NEW] Drug economics:** Sample-hospital and city-pharmacy sales of ibrutinib capsules in China totaled about CNY399 million in 2025, while Tianyu's cumulative research and development investment in the product was CNY7.6208 million as of the announcement [18].
  • **[NEW] National reimbursement:** The 2026 national reimbursement drug list renewed olverembatinib after renegotiation, with coverage for two adult groups: chronic-phase chronic myeloid leukemia resistant to or intolerant of first- and second-generation tyrosine-kinase inhibitors, and T315I-mutated chronic myeloid leukemia in chronic or accelerated phase [19]. The drug was approved in 2021 as China's first and the world's second listed third-generation BCR-ABL inhibitor [19].
  • **[NEW] Labor pipeline:** The 2027 national college-graduate cohort was projected at 12.99 million, with authorities promising stronger coordination to keep overall graduate employment stable [20].
  • **[NEW] Housing controls:** Beike had refused more than 5,000 risky transactions, while escrow regulation in the second-hand housing market remained difficult [21].
  • **[NEW] Data assets:** Jinbei Automobile said its subsidiary's first batch of data assets had completed rights-confirmation registration as the Jinzhi Variable Data Factory advanced compliant construction of data-factor use [22].

5. Diplomacy and Monitoring Tests

  • **[NEW] Leaders' meeting:** The first China-Russia-US summit involving President Xi Jinping, Russian President Vladimir Putin and US President Donald Trump in Shenzhen ended on November 19 [23].
  • **[NEW] US position:** Trump thanked China for its warm reception, said the relationship had made significant progress over more than 40 years of diplomatic ties, cited cooperation on fentanyl, called for cooperation in agriculture, energy and super-intelligence, and said the United States does not support Taiwan independence [24].
  • **[NEW] APEC framing:** Xi's APEC speech called for building an Asia-Pacific community with harmony and shared effort, while companion reports emphasized innovation and a new cooperative vision [8][5][6].
  • **[NEW] Regional view:** A US healthcare executive said China's economic diversification was important to Asia-Pacific development [7].
  • **[ONGOING] Domestic falsifier:** The funding-and-investment read weakens if postponed bank issues return, AAA- three-year Tier-2 and perpetual-bond yields retreat from 1.73% and 1.75%, and the private-investment decline narrows from 10.1%; it strengthens if cancellations expand and the decline deepens [2][3].
  • **[ONGOING] Diplomatic test:** The summit's economic signal requires follow-through in the areas Trump named—agriculture, energy and super-intelligence—rather than only statements about stability and cooperation [24].

SOURCE TRAIL

Citations

24 citation records

  1. [1]
  2. [2]
  3. [3]
  4. [4]

    财联社 · 电报北京3宗涉宅用地92.47亿元成交 ↗

  5. [5]
  6. [6]

    新华社(经济口,Google News 聚合)聚焦APEC丨亚太同心,共话合作新愿景 - 新华网 ↗

  7. [7]
  8. [8]
  9. [9]
  10. [10]
  11. [11]
  12. [12]
  13. [13]
  14. [14]
  15. [15]
  16. [16]
  17. [17]
  18. [18]
  19. [19]
  20. [20]
  21. [21]
  22. [22]
  23. [23]

    财联社 · 电报中俄美元首会晤结束 ↗

  24. [24]

    财联社 · 电报特朗普说美国不支持“台独” ↗